FLT3 and acute myeloid leukemia: This followed prior assertions that FLT3 inhibitors could induce cell cycle arrest, thus antagonising the effects of cell cycle-dependent chemotherapy.2 The clinical effects of FLT3 inhibitor priming in patients with FLT3-ITD AML receiving chemotherapy has not been previously reported.